Middle East and Africa Acetaminophen Reagents Market

Market Introduction

The United Arab Emirates (UAE), Saudi Arabia and South Africa are the 3 major countries in the MEA. Saudi Arabia was the largest market for acetaminophen reagents in this region in 2021.  For instance, A study from the Kingdom of Saudi Arabia (KSA) showed that paracetamol overdose accounts for 30% of intentional drug overdose. Increased awareness of health issues and increased consumption of health services contribute to a significant market for diagnostic related market fastening the growth of acetaminophen reagents market. In Saudi Arabia, rising healthcare spending and well-established hospital and tertiary care centers fuel the growth of the market. The government has increased healthcare and social affairs expenditure by 48% to US$ 42.64bn (SR160bn) for the development of new healthcare centers, hospitals, and primary care centers. In addition, the country has a rapidly developing healthcare system that is adopting variously automated and technically advanced techniques for healthcare facilities. Various training and initiatives have been taken to explore the knowledge about the advancement in technology. Availability of limited players present in the market and growing technological advancements in immunoassay-based acetaminophen reagents are the major factor driving the growth of the MEA acetaminophen reagents market.

In case of COVID-19, MEA is highly affected especially South Africa. Countries in the MEA have also widely affected the socio-economic condition by the COVID–19 pandemic. This challenge would be particularly frightening for the region's fragile and conflict-torn states, such as Iraq, Sudan, South Africa, and Yemen, because it will result in reduced imports due to global trade disruptions, which will exacerbate shortages of medical supplies and other goods, resulting in significant price rises. The Middle East countries have registered a growth in the number of COVID cases. The MEA region include countries such as South Africa, the UAE, and Saudi Arabia. These countries have also registered a significant number of positive coronavirus infection cases. These regions are developing in terms of the pharmaceutical industry. The countries in these regions are highly dependent on pharmaceutical products imported from developed countries. For instance, in April 2020, the government leveraged approvals for hydroxychloroquine and paracetamol export to expedite import of Covid-19 rapid testing kits, masks and personal protection equipment, or PPE. The lockdown has affected the supply chain of various companies in these regions. However, as the crisis continues and government relaxations on the import of the pharmaceutical products are expected to witness sluggish growth for a few years.

Market Overview and Dynamics

The MEA acetaminophen reagents market is expected to grow from US$ 27.88 million in 2021 to US$ 36.54 million by 2028; it is estimated to grow at a CAGR of 3.9% from 2021 to 2028.  Acetaminophen tests measure excess amount of drug content in blood to diagnose its overdose, assess the risk of liver damage, and help decide the need for treatment. Acetaminophen toxicity is diagnosed through various diagnostic tests, such as an acetaminophen level, electrolytes, kidney function tests, and liver function tests. Proper diagnosis of acetaminophen level and accurate treatment are essential for a positive outcome. Increasing usage of OTC acetaminophen in several symptomatic treatments increases the volume for acetaminophen testing. An acetaminophen test is required when a person is suspected of taking an overdose of acetaminophen or shows signs and symptoms of toxicity, such as vomiting, nausea, and abdominal pain. An overdose can be classified into four stages. Stage 1 occurs within 24 hours that is characterized by nausea, vomiting, and malaise. Stage 2 occurs within 24 to 27 hours and involves increased nausea and vomiting, pain in the upper right abdomen, and worsening hepatic and renal toxicity. In stage 3, liver function abnormalities peak between day 3 and day 4 and depending upon the degree of poisoning, hepatic failure with jaundice and bleeding diathesis can also occur, leading to multiorgan failure and death in this phase. Patients who survive stage 3 progress to stage 4 with a slow recovery and normalization of the liver between days 4 and day 7. Furthermore, several medical administrations takes various steps to reduce the acetaminophen maximum dosage unit strength in prescription drug products, such as safety labeling changes, including a new boxed warning, for acetaminophen-containing prescription drug products. It helps prevent liver damage that can occur due to acetaminophen overdose, a severe public health problem. Hence, drug level testing is performed to prevent severe damage to liver that also helps to suggests medication accordingly to provide efficient treatment to the patients.  Therefore, as the acetaminophen reagents are specific drug testing reagents that help to determine the level of drug in the sample during the testing process, so the high adoption of acetaminophen testing (immunoassay testing) due to increased cases of overdoses and surged inclination toward OTC drugs drive the growth of the MEA acetaminophen reagents market.

Key Market Segments

In terms of product, the antibody/substrate reagent segment accounted for the largest share of the MEA acetaminophen reagents market in 2020. In terms of application, the enzymatic assays segment held a larger market share of the MEA acetaminophen reagents market in 2020. Further, the hospitals segment held a larger share of the MEA acetaminophen reagents market based on end user in 2020.  

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the MEA acetaminophen reagents market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; American Screening Corporation, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Biorbyt Ltd.; Randox Laboratories, Ltd.; Siemens Healthineers AG; and Thermo Fisher Scientific Inc.   among others.  

Reasons to buy report

• To understand the MEA acetaminophen reagents market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for MEA acetaminophen reagents market
• Efficiently plan M&A and partnership deals in MEA acetaminophen reagents market by identifying market segments with the most promising probable sales  
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form MEA acetaminophen reagents market
• Obtain market revenue forecast for market by various segments from 2021-2028 in MEA region.

MEA Acetaminophen Reagents Market Segmentation

MEA Acetaminophen Reagents Market - By Product

• Antibody/Substrate Reagent
• Enzyme Reagent
• Acetaminophen Antiserum
• Acetaminophen Fluorescein Tracer
• Pretreatment Solution

MEA Acetaminophen Reagents Market -

By Application

• Enzymatic Assays
• Immunoassay 

MEA Acetaminophen Reagents Market -

By End User

• Hospitals
• Diagnostics Laboratories
• POC Testing
• Forensic Laboratories
• Others

MEA Acetaminophen Reagents Market - By Country

• Saudi Arabia
• South Africa
• UAE
• Rest of MEA

MEA Acetaminophen Reagents Market - Company Profiles

• Abbott
• American Screening Corporation, Inc.
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• Biorbyt Ltd.
• Randox Laboratories, Ltd. 
• Siemens Healthineers AG 
• Thermo Fisher Scientific Inc.  

Middle East and Africa Acetaminophen Reagents Strategic Insights

Strategic insights for the Middle East and Africa Acetaminophen Reagents provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East and Africa Acetaminophen Reagents Report Scope

Middle East and Africa Acetaminophen Reagents Regional Insights

The geographic scope of the Middle East and Africa Acetaminophen Reagents refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.